Table 3 Characteristics of patients at 3-months after OLT between the training set and validation set
Characteristic | Training set (n = 293) | Validation set (n = 106) | p-value |
|---|---|---|---|
Neutrophils (× 109/L) | 2.49 (1.86-3.50) | 2.61 (1.92-3.57) | 0.43 |
Lymphocyte (×  109/L) | 1.15 (0.88-1.54) | 1.16 (0.8-1.57) | 0.70 |
Hemoglobin (g/L) | 130 (117-139) | 130 (119-141) | 0.64 |
Platelet (× 109/L) | 114 (90-175) | 132 (93-186) | 0.11 |
NLR | 2.17 (1.49-3.06) | 2.33 (1.58-3.50) | 0.22 |
PLR | 102.99 (76.47-151.76) | 120.41 (87.33-161.27) | 0.04 |
N/LP | 0.018 (0.012-0.027) | 0.018 (0.01-0.029) | 0.92 |
Albumin (g/L) | 41.60 (37.41-44.70) | 42.80 (39.50-45.42) | 0.02 |
TBIL (μmol/L) | 15.26 (11.33-19.49) | 15.30 (11.08-21.25) | 0.88 |
DBIL (μmol/L) | 5.22 (4.14-7.40) | 5.48 (3.80-7.79) | 0.89 |
ALT (U/L) | 21.00 (15.00-37.00) | 22.00 (14.00-36.00) | 0.95 |
AST (U/L) | 20.00 (16.00-27.00) | 20.00 (16.00-30.00) | 0.34 |
Glu (mmol/L) | 5.47 (4.79-6.28) | 5.37 (4.86-6.35) | 0.87 |
CysC (mg/L) | 1.135 (0.965-1.375) | 1.125 (0.985-1.325) | 0.99 |
C1q (mg/L) | 168 (139-198) | 171 (145-194) | 0.74 |
BUN (mmol/L) | 5.90 (4.91-7.58) | 5.97 (4.94-6.97) | 0.70 |
sCr (μmol/L) | 85.00 (66.00-93.00) | 80.00 (60.00-93.00) | 0.19 |
UA (μmol/L) | 359.00 (305.00-439.00) | 356.00 (292.00-416.00) | 0.38 |
eGFR (mL/min/1.73 m2) | 92.76 (80.28-131.31) | 99.72 (80.29-147.29) | 0.24 |
Average concentration of FK506 | 7.00 (5.40-8.50) | 7.35 (5.15-8.98) | 0.51 |
Average concentration of CsA | 390.60 (246.25-575.35) | 121.28 (73.68-478.19) | 0.09 |
Average concentration of Rapamycin | 4.14 (3.59-5.12) | 3.97 (2.92-4.51) | 0.33 |